Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0101 Transporter Info | ||||
Gene Name | SLC16A10 | ||||
Transporter Name | Monocarboxylate transporter 10 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Pancretic ductal adenocarcinoma |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC16A10 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
5'UTR (cg14794191) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:6.04E-03; Z-score:-3.82E-01 | ||
Methylation in Case |
8.55E-01 (Median) | Methylation in Control | 8.66E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC16A10 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
TSS1500 (cg09454187) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.26E+00 | Statistic Test | p-value:6.04E-05; Z-score:1.46E+00 | ||
Methylation in Case |
8.08E-01 (Median) | Methylation in Control | 6.39E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC16A10 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg16782807) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.99E+00 | Statistic Test | p-value:3.46E-12; Z-score:1.92E+00 | ||
Methylation in Case |
3.68E-01 (Median) | Methylation in Control | 1.85E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC16A10 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg23250019) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.33E+00 | Statistic Test | p-value:3.69E-08; Z-score:-1.79E+00 | ||
Methylation in Case |
5.47E-01 (Median) | Methylation in Control | 7.30E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC16A10 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg14047153) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.29E+00 | Statistic Test | p-value:1.16E-04; Z-score:-1.50E+00 | ||
Methylation in Case |
7.09E-01 (Median) | Methylation in Control | 9.17E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC16A10 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg01551177) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:2.11E-03; Z-score:7.32E-01 | ||
Methylation in Case |
7.33E-01 (Median) | Methylation in Control | 6.83E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC16A10 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg00378292) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:1.14E-02; Z-score:-7.36E-01 | ||
Methylation in Case |
3.66E-01 (Median) | Methylation in Control | 3.91E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC16A10 in clear cell renal cell carcinoma | [ 2 ] | |||
Location |
TSS1500 (cg14849782) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.22E+00 | Statistic Test | p-value:5.58E-03; Z-score:9.07E-01 | ||
Methylation in Case |
2.08E-02 (Median) | Methylation in Control | 1.71E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC16A10 in clear cell renal cell carcinoma | [ 2 ] | |||
Location |
TSS1500 (cg15721981) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:2.29E-02; Z-score:3.51E-01 | ||
Methylation in Case |
4.80E-02 (Median) | Methylation in Control | 4.39E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC16A10 in clear cell renal cell carcinoma | [ 2 ] | |||
Location |
TSS200 (cg15822346) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.40E+00 | Statistic Test | p-value:7.31E-05; Z-score:-1.16E+00 | ||
Methylation in Case |
4.10E-02 (Median) | Methylation in Control | 5.76E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC16A10 in clear cell renal cell carcinoma | [ 2 ] | |||
Location |
TSS200 (cg18588052) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.22E+00 | Statistic Test | p-value:3.25E-03; Z-score:-7.08E-01 | ||
Methylation in Case |
2.47E-02 (Median) | Methylation in Control | 3.01E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC16A10 in clear cell renal cell carcinoma | [ 2 ] | |||
Location |
TSS200 (cg25357155) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.01E+00 | Statistic Test | p-value:3.40E-02; Z-score:9.71E-02 | ||
Methylation in Case |
1.24E-02 (Median) | Methylation in Control | 1.22E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC16A10 in clear cell renal cell carcinoma | [ 2 ] | |||
Location |
1stExon (cg07940485) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:1.62E-06; Z-score:7.58E-01 | ||
Methylation in Case |
1.45E-02 (Median) | Methylation in Control | 1.36E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC16A10 in colon adenocarcinoma | [ 3 ] | |||
Location |
TSS1500 (cg07104116) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.21E+00 | Statistic Test | p-value:2.71E-05; Z-score:-1.80E+00 | ||
Methylation in Case |
4.84E-01 (Median) | Methylation in Control | 5.85E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC16A10 in colon adenocarcinoma | [ 3 ] | |||
Location |
TSS1500 (cg06746492) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.19E+00 | Statistic Test | p-value:5.29E-04; Z-score:-2.41E+00 | ||
Methylation in Case |
6.44E-01 (Median) | Methylation in Control | 7.65E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC16A10 in colon adenocarcinoma | [ 3 ] | |||
Location |
TSS1500 (cg10528482) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:4.98E-03; Z-score:1.46E+00 | ||
Methylation in Case |
7.33E-01 (Median) | Methylation in Control | 6.64E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC16A10 in colon adenocarcinoma | [ 3 ] | |||
Location |
Body (cg14495732) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.30E+00 | Statistic Test | p-value:2.00E-06; Z-score:-4.80E+00 | ||
Methylation in Case |
5.70E-01 (Median) | Methylation in Control | 7.40E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC16A10 in colon adenocarcinoma | [ 3 ] | |||
Location |
Body (cg20438663) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:9.02E-04; Z-score:1.28E+00 | ||
Methylation in Case |
7.27E-01 (Median) | Methylation in Control | 6.83E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC16A10 in colon adenocarcinoma | [ 3 ] | |||
Location |
Body (cg01704999) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.13E+00 | Statistic Test | p-value:3.40E-03; Z-score:1.05E+00 | ||
Methylation in Case |
1.41E-01 (Median) | Methylation in Control | 1.24E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC16A10 in hepatocellular carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg14074641) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.38E+00 | Statistic Test | p-value:7.16E-16; Z-score:-6.28E+00 | ||
Methylation in Case |
5.56E-01 (Median) | Methylation in Control | 7.66E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC16A10 in hepatocellular carcinoma | [ 4 ] | |||
Location |
Body (cg13463516) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.45E+00 | Statistic Test | p-value:6.87E-16; Z-score:-3.47E+00 | ||
Methylation in Case |
3.75E-01 (Median) | Methylation in Control | 5.43E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC16A10 in hepatocellular carcinoma | [ 4 ] | |||
Location |
Body (cg05218653) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.31E+00 | Statistic Test | p-value:2.41E-11; Z-score:-5.89E+00 | ||
Methylation in Case |
7.42E-01 (Median) | Methylation in Control | 9.69E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC16A10 in hepatocellular carcinoma | [ 4 ] | |||
Location |
Body (cg21276197) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.01E+00 | Statistic Test | p-value:3.80E-02; Z-score:6.28E-02 | ||
Methylation in Case |
4.67E-02 (Median) | Methylation in Control | 4.62E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC16A10 in panic disorder | [ 5 ] | |||
Location |
TSS1500 (cg14849782) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:9.78E-01 | Statistic Test | p-value:2.35E-02; Z-score:4.52E-01 | ||
Methylation in Case |
-5.18E+00 (Median) | Methylation in Control | -5.29E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC16A10 in systemic lupus erythematosus | [ 6 ] | |||
Location |
TSS1500 (cg15721981) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:9.13E-03; Z-score:-1.28E-01 | ||
Methylation in Case |
1.24E-01 (Median) | Methylation in Control | 1.30E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC16A10 in systemic lupus erythematosus | [ 6 ] | |||
Location |
TSS200 (cg26912984) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:3.89E-03; Z-score:-2.16E-01 | ||
Methylation in Case |
1.25E-01 (Median) | Methylation in Control | 1.31E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC16A10 in systemic lupus erythematosus | [ 6 ] | |||
Location |
TSS200 (cg24499517) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:4.02E-02; Z-score:1.65E-01 | ||
Methylation in Case |
1.57E-02 (Median) | Methylation in Control | 1.49E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC16A10 in systemic lupus erythematosus | [ 6 ] | |||
Location |
Body (cg18485596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:2.05E-04; Z-score:3.35E-01 | ||
Methylation in Case |
2.42E-01 (Median) | Methylation in Control | 2.22E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC16A10 in bladder cancer | [ 7 ] | |||
Location |
TSS200 (cg26912984) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.16E+00 | Statistic Test | p-value:1.46E-02; Z-score:-1.48E+00 | ||
Methylation in Case |
1.10E-01 (Median) | Methylation in Control | 1.27E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC16A10 in bladder cancer | [ 7 ] | |||
Location |
TSS200 (cg18588052) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.48E+00 | Statistic Test | p-value:1.60E-02; Z-score:-1.87E+00 | ||
Methylation in Case |
6.30E-02 (Median) | Methylation in Control | 9.32E-02 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC16A10 in bladder cancer | [ 7 ] | |||
Location |
TSS200 (cg15822346) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.25E+00 | Statistic Test | p-value:4.57E-02; Z-score:-1.56E+00 | ||
Methylation in Case |
9.83E-02 (Median) | Methylation in Control | 1.23E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC16A10 in breast cancer | [ 8 ] | |||
Location |
TSS200 (cg24499517) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:1.04E-02; Z-score:7.21E-02 | ||
Methylation in Case |
1.47E-02 (Median) | Methylation in Control | 1.39E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC16A10 in breast cancer | [ 8 ] | |||
Location |
TSS200 (cg18588052) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.25E+00 | Statistic Test | p-value:1.94E-02; Z-score:-3.85E-01 | ||
Methylation in Case |
3.59E-02 (Median) | Methylation in Control | 4.49E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC16A10 in breast cancer | [ 8 ] | |||
Location |
TSS200 (cg25357155) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:2.86E-02; Z-score:-2.93E-02 | ||
Methylation in Case |
1.04E-02 (Median) | Methylation in Control | 1.07E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC16A10 in breast cancer | [ 8 ] | |||
Location |
1stExon (cg07940485) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.33E+00 | Statistic Test | p-value:9.77E-04; Z-score:3.55E-01 | ||
Methylation in Case |
9.38E-03 (Median) | Methylation in Control | 7.06E-03 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC16A10 in breast cancer | [ 8 ] | |||
Location |
Body (cg03181943) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.18E+00 | Statistic Test | p-value:2.14E-06; Z-score:2.14E+00 | ||
Methylation in Case |
7.65E-01 (Median) | Methylation in Control | 6.48E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC16A10 in breast cancer | [ 8 ] | |||
Location |
Body (cg21276197) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:2.81E-05; Z-score:1.50E-01 | ||
Methylation in Case |
8.24E-02 (Median) | Methylation in Control | 7.82E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC16A10 in breast cancer | [ 8 ] | |||
Location |
Body (cg16300317) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.00E+00 | Statistic Test | p-value:1.53E-03; Z-score:7.76E-03 | ||
Methylation in Case |
7.10E-02 (Median) | Methylation in Control | 7.08E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC16A10 in HIV infection | [ 9 ] | |||
Location |
TSS200 (cg18588052) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.17E+00 | Statistic Test | p-value:1.26E-02; Z-score:4.67E-01 | ||
Methylation in Case |
3.65E-02 (Median) | Methylation in Control | 3.12E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC16A10 in HIV infection | [ 9 ] | |||
Location |
1stExon (cg07940485) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.88E+00 | Statistic Test | p-value:2.89E-02; Z-score:5.81E-01 | ||
Methylation in Case |
5.02E-03 (Median) | Methylation in Control | 2.66E-03 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC16A10 in HIV infection | [ 9 ] | |||
Location |
Body (cg18485596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.41E+00 | Statistic Test | p-value:1.77E-08; Z-score:2.33E+00 | ||
Methylation in Case |
1.98E-01 (Median) | Methylation in Control | 1.41E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC16A10 in lung adenocarcinoma | [ 10 ] | |||
Location |
TSS200 (cg15822346) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.25E+00 | Statistic Test | p-value:8.13E-03; Z-score:-1.47E+00 | ||
Methylation in Case |
1.11E-01 (Median) | Methylation in Control | 1.39E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC16A10 in lung adenocarcinoma | [ 10 ] | |||
Location |
TSS200 (cg24499517) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.36E+00 | Statistic Test | p-value:3.11E-02; Z-score:-1.03E+00 | ||
Methylation in Case |
2.28E-02 (Median) | Methylation in Control | 3.09E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC16A10 in lung adenocarcinoma | [ 10 ] | |||
Location |
Body (cg16300317) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.17E+00 | Statistic Test | p-value:8.23E-03; Z-score:1.31E+00 | ||
Methylation in Case |
1.11E-01 (Median) | Methylation in Control | 9.53E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC16A10 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
1stExon (cg07940485) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.24E+00 | Statistic Test | p-value:2.96E-21; Z-score:-3.32E+00 | ||
Methylation in Case |
6.90E-01 (Median) | Methylation in Control | 8.55E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC16A10 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
Body (cg03181943) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:2.59E-04; Z-score:-8.52E-01 | ||
Methylation in Case |
8.69E-01 (Median) | Methylation in Control | 9.02E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC16A10 in colorectal cancer | [ 12 ] | |||
Location |
Body (cg03181943) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:7.87E-03; Z-score:-7.98E-01 | ||
Methylation in Case |
8.91E-01 (Median) | Methylation in Control | 9.11E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
Unclear Phenotype |
56 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
miR-122 directly targets SLC16A10 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-122 | miRNA Mature ID | miR-122-5p | ||
miRNA Sequence |
UGGAGUGUGACAAUGGUGUUUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Left ventricular cardiac tissues of human | ||||
Epigenetic Phenomenon2 |
miR-1250 directly targets SLC16A10 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-1250 | miRNA Mature ID | miR-1250-3p | ||
miRNA Sequence |
ACAUUUUCCAGCCCAUUCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon3 |
miR-1281 directly targets SLC16A10 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-1281 | miRNA Mature ID | miR-1281 | ||
miRNA Sequence |
UCGCCUCCUCCUCUCCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Left ventricular cardiac tissues of human | ||||
Epigenetic Phenomenon4 |
miR-1304 directly targets SLC16A10 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-1304 | miRNA Mature ID | miR-1304-3p | ||
miRNA Sequence |
UCUCACUGUAGCCUCGAACCCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Left ventricular cardiac tissues of human | ||||
Epigenetic Phenomenon5 |
miR-140 directly targets SLC16A10 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-140 | miRNA Mature ID | miR-140-3p | ||
miRNA Sequence |
UACCACAGGGUAGAACCACGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon6 |
miR-143 directly targets SLC16A10 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-143 | miRNA Mature ID | miR-143-5p | ||
miRNA Sequence |
GGUGCAGUGCUGCAUCUCUGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Left ventricular cardiac tissues of human | ||||
Epigenetic Phenomenon7 |
miR-145 directly targets SLC16A10 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-145 | miRNA Mature ID | miR-145-5p | ||
miRNA Sequence |
GUCCAGUUUUCCCAGGAAUCCCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon8 |
miR-153 directly targets SLC16A10 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-153 | miRNA Mature ID | miR-153-5p | ||
miRNA Sequence |
UCAUUUUUGUGAUGUUGCAGCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon9 |
miR-1825 directly targets SLC16A10 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1825 | miRNA Mature ID | miR-1825 | ||
miRNA Sequence |
UCCAGUGCCCUCCUCUCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon10 |
miR-199a directly targets SLC16A10 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-199a | miRNA Mature ID | miR-199a-5p | ||
miRNA Sequence |
CCCAGUGUUCAGACUACCUGUUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon11 |
miR-199b directly targets SLC16A10 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-199b | miRNA Mature ID | miR-199b-5p | ||
miRNA Sequence |
CCCAGUGUUUAGACUAUCUGUUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon12 |
miR-21 directly targets SLC16A10 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Microarray | ||
miRNA Stemloop ID |
miR-21 | miRNA Mature ID | miR-21-5p | ||
miRNA Sequence |
UAGCUUAUCAGACUGAUGUUGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
miR-2115 directly targets SLC16A10 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-2115 | miRNA Mature ID | miR-2115-5p | ||
miRNA Sequence |
AGCUUCCAUGACUCCUGAUGGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon14 |
miR-3135b directly targets SLC16A10 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3135b | miRNA Mature ID | miR-3135b | ||
miRNA Sequence |
GGCUGGAGCGAGUGCAGUGGUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Left ventricular cardiac tissues of human | ||||
Epigenetic Phenomenon15 |
miR-3149 directly targets SLC16A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3149 | miRNA Mature ID | miR-3149 | ||
miRNA Sequence |
UUUGUAUGGAUAUGUGUGUGUAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon16 |
miR-3158 directly targets SLC16A10 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3158 | miRNA Mature ID | miR-3158-5p | ||
miRNA Sequence |
CCUGCAGAGAGGAAGCCCUUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon17 |
miR-3166 directly targets SLC16A10 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3166 | miRNA Mature ID | miR-3166 | ||
miRNA Sequence |
CGCAGACAAUGCCUACUGGCCUA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon18 |
miR-3190 directly targets SLC16A10 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3190 | miRNA Mature ID | miR-3190-5p | ||
miRNA Sequence |
UCUGGCCAGCUACGUCCCCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon19 |
miR-3529 directly targets SLC16A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3529 | miRNA Mature ID | miR-3529-5p | ||
miRNA Sequence |
AGGUAGACUGGGAUUUGUUGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon20 |
miR-3652 directly targets SLC16A10 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3652 | miRNA Mature ID | miR-3652 | ||
miRNA Sequence |
CGGCUGGAGGUGUGAGGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Left ventricular cardiac tissues of human | ||||
Epigenetic Phenomenon21 |
miR-3674 directly targets SLC16A10 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3674 | miRNA Mature ID | miR-3674 | ||
miRNA Sequence |
AUUGUAGAACCUAAGAUUGGCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon22 |
miR-379 directly targets SLC16A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-379 | miRNA Mature ID | miR-379-5p | ||
miRNA Sequence |
UGGUAGACUAUGGAACGUAGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon23 |
miR-3926 directly targets SLC16A10 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3926 | miRNA Mature ID | miR-3926 | ||
miRNA Sequence |
UGGCCAAAAAGCAGGCAGAGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon24 |
miR-4418 directly targets SLC16A10 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4418 | miRNA Mature ID | miR-4418 | ||
miRNA Sequence |
CACUGCAGGACUCAGCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon25 |
miR-4428 directly targets SLC16A10 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4428 | miRNA Mature ID | miR-4428 | ||
miRNA Sequence |
CAAGGAGACGGGAACAUGGAGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon26 |
miR-4430 directly targets SLC16A10 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4430 | miRNA Mature ID | miR-4430 | ||
miRNA Sequence |
AGGCUGGAGUGAGCGGAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Left ventricular cardiac tissues of human | ||||
Epigenetic Phenomenon27 |
miR-4438 directly targets SLC16A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4438 | miRNA Mature ID | miR-4438 | ||
miRNA Sequence |
CACAGGCUUAGAAAAGACAGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon28 |
miR-4451 directly targets SLC16A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4451 | miRNA Mature ID | miR-4451 | ||
miRNA Sequence |
UGGUAGAGCUGAGGACA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon29 |
miR-4537 directly targets SLC16A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4537 | miRNA Mature ID | miR-4537 | ||
miRNA Sequence |
UGAGCCGAGCUGAGCUUAGCUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon30 |
miR-4643 directly targets SLC16A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4643 | miRNA Mature ID | miR-4643 | ||
miRNA Sequence |
GACACAUGACCAUAAAUGCUAA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon31 |
miR-4650 directly targets SLC16A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4650 | miRNA Mature ID | miR-4650-3p | ||
miRNA Sequence |
AGGUAGAAUGAGGCCUGACAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon32 |
miR-4717 directly targets SLC16A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4717 | miRNA Mature ID | miR-4717-3p | ||
miRNA Sequence |
ACACAUGGGUGGCUGUGGCCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon33 |
miR-4771 directly targets SLC16A10 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4771 | miRNA Mature ID | miR-4771 | ||
miRNA Sequence |
AGCAGACUUGACCUACAAUUA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon34 |
miR-4772 directly targets SLC16A10 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4772 | miRNA Mature ID | miR-4772-3p | ||
miRNA Sequence |
CCUGCAACUUUGCCUGAUCAGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Left ventricular cardiac tissues of human | ||||
Epigenetic Phenomenon35 |
miR-499b directly targets SLC16A10 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-499b | miRNA Mature ID | miR-499b-5p | ||
miRNA Sequence |
ACAGACUUGCUGUGAUGUUCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon36 |
miR-500b directly targets SLC16A10 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-500b | miRNA Mature ID | miR-500b-3p | ||
miRNA Sequence |
GCACCCAGGCAAGGAUUCUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon37 |
miR-504 directly targets SLC16A10 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-504 | miRNA Mature ID | miR-504-3p | ||
miRNA Sequence |
GGGAGUGCAGGGCAGGGUUUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Left ventricular cardiac tissues of human | ||||
Epigenetic Phenomenon38 |
miR-509 directly targets SLC16A10 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-509 | miRNA Mature ID | miR-509-5p | ||
miRNA Sequence |
UACUGCAGACAGUGGCAAUCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon39 |
miR-5195 directly targets SLC16A10 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-5195 | miRNA Mature ID | miR-5195-3p | ||
miRNA Sequence |
AUCCAGUUCUCUGAGGGGGCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon40 |
miR-548s directly targets SLC16A10 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-548s | miRNA Mature ID | miR-548s | ||
miRNA Sequence |
AUGGCCAAAACUGCAGUUAUUUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon41 |
miR-5693 directly targets SLC16A10 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-5693 | miRNA Mature ID | miR-5693 | ||
miRNA Sequence |
GCAGUGGCUCUGAAAUGAACUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Left ventricular cardiac tissues of human | ||||
Epigenetic Phenomenon42 |
miR-5698 directly targets SLC16A10 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-5698 | miRNA Mature ID | miR-5698 | ||
miRNA Sequence |
UGGGGGAGUGCAGUGAUUGUGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Left ventricular cardiac tissues of human | ||||
Epigenetic Phenomenon43 |
miR-590 directly targets SLC16A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-590 | miRNA Mature ID | miR-590-3p | ||
miRNA Sequence |
UAAUUUUAUGUAUAAGCUAGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon44 |
miR-624 directly targets SLC16A10 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-624 | miRNA Mature ID | miR-624-3p | ||
miRNA Sequence |
CACAAGGUAUUGGUAUUACCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon45 |
miR-6499 directly targets SLC16A10 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6499 | miRNA Mature ID | miR-6499-3p | ||
miRNA Sequence |
AGCAGUGUUUGUUUUGCCCACA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Left ventricular cardiac tissues of human | ||||
Epigenetic Phenomenon46 |
miR-6504 directly targets SLC16A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6504 | miRNA Mature ID | miR-6504-3p | ||
miRNA Sequence |
CAUUACAGCACAGCCAUUCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon47 |
miR-6720 directly targets SLC16A10 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6720 | miRNA Mature ID | miR-6720-3p | ||
miRNA Sequence |
CGCGCCUGCAGGAACUGGUAGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon48 |
miR-6722 directly targets SLC16A10 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6722 | miRNA Mature ID | miR-6722-5p | ||
miRNA Sequence |
AGGCGCACCCGACCACAUGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Left ventricular cardiac tissues of human | ||||
Epigenetic Phenomenon49 |
miR-6746 directly targets SLC16A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6746 | miRNA Mature ID | miR-6746-3p | ||
miRNA Sequence |
CAGCCGCCGCCUGUCUCCACAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon50 |
miR-6758 directly targets SLC16A10 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6758 | miRNA Mature ID | miR-6758-3p | ||
miRNA Sequence |
ACUCAUUCUCCUCUGUCCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon51 |
miR-6807 directly targets SLC16A10 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6807 | miRNA Mature ID | miR-6807-5p | ||
miRNA Sequence |
GUGAGCCAGUGGAAUGGAGAGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon52 |
miR-6832 directly targets SLC16A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6832 | miRNA Mature ID | miR-6832-5p | ||
miRNA Sequence |
AGUAGAGAGGAAAAGUUAGGGUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon53 |
miR-6879 directly targets SLC16A10 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6879 | miRNA Mature ID | miR-6879-3p | ||
miRNA Sequence |
UGUCACCCGCUCCUUGCCCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon54 |
miR-6890 directly targets SLC16A10 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6890 | miRNA Mature ID | miR-6890-3p | ||
miRNA Sequence |
CCACUGCCUAUGCCCCACAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Left ventricular cardiac tissues of human | ||||
Epigenetic Phenomenon55 |
miR-7151 directly targets SLC16A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-7151 | miRNA Mature ID | miR-7151-3p | ||
miRNA Sequence |
CUACAGGCUGGAAUGGGCUCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon56 |
miR-942 directly targets SLC16A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-942 | miRNA Mature ID | miR-942-3p | ||
miRNA Sequence |
CACAUGGCCGAAACAGAGAAGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.